Press Release

QT Imaging Holdings Announces Partnership with Premier Cancer Center, The Vincere Cancer Center in Scottsdale, AZ

NOVATO, Calif.–(BUSINESS WIRE)–QT Imaging Holdings, Inc. (NASDAQ:QTI) (“QT Imaging”) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, together with its strategic business and distribution partner, is proud to announce its partnership with The Vincere Cancer Center in Scottsdale, AZ.

“In recent years, there has been an increased rate of breast cancer incidents, especially amongst women younger than 40, the recommended age of initial mammogram screening”

The Vincere Cancer Center is a top cancer center in the U.S. Founded by Dr. Vershalee Shukla and Dr. Pablo Prichard, the Center focuses on cancer prevention, early detection, and specializes in radiation therapy, surgery, and chemotherapy. Using innovative precision technology, the Center is renowned for its comprehensive cancer services. Dr. Prichard and Dr. Shukla, a board-certified reconstructive surgeon and radiation oncologist, built their practice to deliver superior cancer care to a variety of patients. They employ innovative technology to mitigate against over-diagnoses while ensuring cancer is not missed. Dr. Shukla, a long-standing supporter of QT Imaging and its technology, applies the QT Imaging Breast Acoustic CT™ Scanner in their breast screening environment.

“In recent years, there has been an increased rate of breast cancer incidents, especially amongst women younger than 40, the recommended age of initial mammogram screening,” said Dr. Shukla, Director of The Vincere Cancer Center. “Despite this, there has been very little technological advancement in detection of breast cancer that is suitable and accessible to all women. By harnessing the power of the QT Imaging Breast Acoustic CT™ Scanner and eliminating the discomfort associated with traditional methods, our partnership with QT Imaging is redefining standards of care and empowering patients with precision and safety.”

“The QT Imaging team’s mission is to expand access to medical imaging while ensuring superior patient experience, lowering costs for providers, and improving health outcomes,” said Dr. Raluca Dinu, Chief Executive Officer. “We are incredibly excited about the opportunity to work with such a prestigious cancer center and to be able to provide women a choice in their care that is safe and doesn’t jeopardize accuracy or accessibility. The partnership with Vincere Cancer Center represents the continuation of our swift commercialization plan since the company went public two months ago.”

About QT Holding, Inc.

QT Imaging Holdings, Inc. is a public (NASDAQ: QTI) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging, please visit the company’s website at www.qtimaging.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as “will,” and “expect,” or the negative thereof or comparable terminology, and include (without limitation) statements regarding the partnership between QT Imaging and The Vincere Cancer Center, the QT Imaging Breast Acoustic CTTM Scanner, plans for QT Imaging, new product development and introduction, and product sales growth and projected revenues. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. These risks include, but are not limited to: the ability of the parties to sell and deploy the QT Imaging Breast Acoustic CTTM Scanner, the ability to extend product offerings into new areas or products, the ability to commercialize technology, unexpected occurrences that deter the full documentation and “bring to market” plan for products, trends and fluctuations in the industry, changes in demand and purchasing volume of customers, unpredictability of suppliers, the ability to attract and retain qualified personnel and the ability to move product sales to production levels. Additional factors that could cause actual results to differ are discussed under the heading “Risk Factors” and in other sections of QT Imaging’s (and its predecessor, GigCapital5, Inc.) filings with the SEC, and in its other current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to QT Imaging as of the date hereof, and QT Imaging assumes no obligation to update any forward-looking statement.

Contacts

For media inquiries:
Susan Schaffler
Head of Communications
Susan.Schaffler@qtimaging.com

Stas Budagov
Chief Financial Officer
Stas.Budagov@qtimaging.com

Skip to content